Prognostic significance of KIT exon 11 deletion mutation in intermediate-risk gastrointestinal stromal tumor
Quek, Richard; Farid, Mohamad; Kanjanapan, Yada; Lim, Cindy; Tan, Iain Beehuat; Kesavan, Sittampalam; Lim, Tony Kiat Hon; Oon, Lynette Lin-Ean; Goh, Brian K P; Chan, Weng Hoong; Teo, Melissa; Yip, Desmond
Aim: Benefit of adjuvant imatinib therapy following curative resection in patients with intermediate-risk gastrointestinal stromal tumor (GIST) is unclear. GIST-specific exon mutations, in particular exon 11 deletions, have been shown to be prognostic. We hypothesize that specific KIT mutations may improve risk stratification in patients with intermediate-risk GIST, identifying a subgroup of patients who may benefit from adjuvant therapy. Methods: In total, 142 GIST patients with complete...[Show more]
|Collections||ANU Research Publications|
|Source:||Asia-Pacific Journal of Clinical Oncology|
|01_Quek_Prognostic_significance_of_KIT_2017.pdf||225.85 kB||Adobe PDF||Request a copy|
|02_Quek_Prognostic_significance_of_KIT_2017.pdf||313.06 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.